Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop drugs

Critical Outcome Technologies Inc. (CVE:COT) uses machine learning and computer science to create clinical and pre-clinical stage drugs with a focus on oncology. Listen to the podcast interview with Dr. Wayne Danter:http://wpmedia.business.financialpost.com/2016/05/dr-wayne-danter-critical-outcome-tech-042616-podcast.mp3  James West: Wayne, thanks for joining us today. Dr. Wayne Danter: Oh, thank you for having me. James West: Wayne, let’s start with an overview of the value proposition for investors in Critical Outcome Technologies Inc. Dr. Wayne Danter: Sure. Critical Outcome Technologies is a clinical stage drug discovery and pre-clinical development company built around a computational platform. So what we do differently is to do much of the discovery work in computer simulations. That allows us to be very cost-effective in terms of identifying high probability drug candidates that we want to take forward.  So for example,…


Link to Full Article: Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop drugs